AI Tokens
Stock Analysis on Net

Baxter International Inc. (NYSE:BAX)

This company has been moved to the archive! The financial data has not been updated since August 4, 2016.

Analysis of Long-term (Investment) Activity Ratios

Microsoft Excel

Long-term Activity Ratios (Summary)

Baxter International Inc., long-term (investment) activity ratios

Microsoft Excel
Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Net fixed asset turnover 2.27 1.92 1.95 2.33 2.51
Total asset turnover 0.48 0.64 0.59 0.70 0.73
Equity turnover 1.13 2.05 1.80 2.05 2.11

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).


The long-term activity ratios exhibit a general trend of declining efficiency in asset and equity utilization between 2011 and 2015. While certain metrics show periodic recovery, the overall trajectory suggests a diminished capacity to generate sales relative to the invested capital base.

Net Fixed Asset Turnover
A decline was observed from 2011 to 2014, with the ratio falling from 2.51 to 1.92. A partial recovery occurred in 2015, as the ratio rose to 2.27, indicating an improvement in the efficiency of leveraging fixed assets to generate revenue toward the end of the period.
Total Asset Turnover
A sustained downward trend is evident, with the ratio decreasing from 0.73 in 2011 to 0.48 by 2015. Although a marginal increase to 0.64 was noted in 2014, the 2015 value represents the lowest efficiency level in the period, suggesting that total assets are generating progressively less revenue.
Equity Turnover
Utilization of equity remained relatively stable between 2011 and 2014, fluctuating between 1.80 and 2.11. However, a significant contraction occurred in 2015, where the ratio dropped sharply to 1.13, indicating a substantial reduction in the revenue generated per unit of shareholder equity.

The divergence observed in 2015—characterized by an improvement in net fixed asset turnover coinciding with a decline in total asset and equity turnovers—suggests that the overall reduction in efficiency was likely driven by factors independent of fixed asset productivity, such as an increase in non-fixed assets or a significant expansion of the equity base.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Net Fixed Asset Turnover

Baxter International Inc., net fixed asset turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Selected Financial Data (US$ in millions)
Net sales 9,968 16,671 15,259 14,190 13,893
Property, plant and equipment, net 4,386 8,698 7,832 6,098 5,525
Long-term Activity Ratio
Net fixed asset turnover1 2.27 1.92 1.95 2.33 2.51
Benchmarks
Net Fixed Asset Turnover, Competitors2
Abbott Laboratories — — — — —
Elevance Health Inc. — — — — —
Intuitive Surgical Inc. — — — — —
Medtronic PLC — — — — —
UnitedHealth Group Inc. — — — — —

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

1 2015 Calculation
Net fixed asset turnover = Net sales ÷ Property, plant and equipment, net
= 9,968 ÷ 4,386 = 2.27

2 Click competitor name to see calculations.


The net fixed asset turnover ratio exhibited a consistent downward trend from 2011 through 2014, followed by a sharp reversal in 2015. This progression indicates a fluctuating relationship between the company's investment in physical infrastructure and its ability to generate revenue from those assets.

Asset Efficiency Decline (2011-2014)
Between 2011 and 2014, the net fixed asset turnover ratio decreased from 2.51 to 1.92. While net sales grew steadily from 13,893 million to 16,671 million during this period, the investment in property, plant, and equipment, net, increased at a more aggressive rate, rising from 5,525 million to 8,698 million. The fact that asset growth outpaced revenue growth resulted in a lower turnover ratio, suggesting a period of intensive capital expansion that had not yet reached peak productivity.
Significant Structural Shift (2015)
The 2015 fiscal year was marked by a substantial contraction in both sales and the asset base. Net sales fell to 9,968 million, and net property, plant, and equipment decreased sharply to 4,386 million. Despite the decline in sales, the proportional reduction in fixed assets was more severe, which drove the net fixed asset turnover ratio back up to 2.27. This reversal suggests a significant divestiture or restructuring of long-term assets, effectively increasing the relative efficiency of the remaining asset base.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Total Asset Turnover

Baxter International Inc., total asset turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Selected Financial Data (US$ in millions)
Net sales 9,968 16,671 15,259 14,190 13,893
Total assets 20,975 25,917 25,869 20,390 19,073
Long-term Activity Ratio
Total asset turnover1 0.48 0.64 0.59 0.70 0.73
Benchmarks
Total Asset Turnover, Competitors2
Abbott Laboratories — — — — —
Elevance Health Inc. — — — — —
Intuitive Surgical Inc. — — — — —
Medtronic PLC — — — — —
UnitedHealth Group Inc. — — — — —

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

1 2015 Calculation
Total asset turnover = Net sales ÷ Total assets
= 9,968 ÷ 20,975 = 0.48

2 Click competitor name to see calculations.


The analysis of total asset turnover from 2011 to 2015 reveals a general decline in asset utilization efficiency, with the ratio decreasing from 0.73 to 0.48 over the five-year period.

Revenue Trends
Net sales demonstrated a steady upward trajectory between 2011 and 2014, increasing from 13,893 million US$ to 16,671 million US$. This growth trend was abruptly reversed in 2015, with net sales falling sharply to 9,968 million US$.
Asset Base Fluctuations
Total assets grew from 19,073 million US$ in 2011 to a peak of 25,917 million US$ in 2014. A significant expansion of the asset base occurred in 2013, which initially outpaced revenue growth and contributed to a decline in turnover efficiency. In 2015, total assets decreased to 20,975 million US$.
Asset Turnover Interpretation
The total asset turnover ratio experienced a downward trend, moving from 0.73 in 2011 to 0.59 in 2013. Although a slight recovery to 0.64 was recorded in 2014, the ratio reached its lowest point of 0.48 in 2015. This indicates that the decline in sales in 2015 was disproportionately larger than the reduction in assets, leading to a marked decrease in the company's ability to generate sales from its investment base.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Equity Turnover

Baxter International Inc., equity turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Selected Financial Data (US$ in millions)
Net sales 9,968 16,671 15,259 14,190 13,893
Total Baxter shareholders’ equity 8,846 8,120 8,463 6,938 6,585
Long-term Activity Ratio
Equity turnover1 1.13 2.05 1.80 2.05 2.11
Benchmarks
Equity Turnover, Competitors2
Abbott Laboratories — — — — —
Elevance Health Inc. — — — — —
Intuitive Surgical Inc. — — — — —
Medtronic PLC — — — — —
UnitedHealth Group Inc. — — — — —

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

1 2015 Calculation
Equity turnover = Net sales ÷ Total Baxter shareholders’ equity
= 9,968 ÷ 8,846 = 1.13

2 Click competitor name to see calculations.


The analysis of investment activity between 2011 and 2015 reveals a significant decline in capital utilization efficiency during the final period. While a consistent ability to generate sales relative to the equity base was maintained for the first four years, a sharp contraction occurred in 2015.

Net Sales Performance
A positive growth trajectory was observed from 2011 to 2014, with sales increasing from US$ 13,893 million to a peak of US$ 16,671 million. This trend reversed abruptly in 2015, as net sales fell to US$ 9,968 million.
Shareholders' Equity Evolution
The total equity base grew steadily from US$ 6,585 million in 2011 to US$ 8,846 million in 2015. Despite a marginal decrease in 2014, the overall trend indicates a consistent expansion of the company's equity over the five-year period.
Equity Turnover Analysis
The equity turnover ratio exhibited relative stability between 2011 and 2014, fluctuating within a range of 1.80 to 2.11. In 2015, the ratio dropped significantly to 1.13. This decline is primarily attributed to the simultaneous decrease in net sales and the increase in total shareholders' equity, reflecting a diminished efficiency in leveraging equity to generate revenue.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?